Dr. Jocelin Huang, MD

Dr. Huang practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Huang's NPI, 1609997808, was assigned on April 3, 2007. Dr. Huang graduated from Pritzker School of Medicine in 2006. Dr. Huang's Minnesota license number on file is 49749.

Dr. Huang's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Huang's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. Dr. Huang is also affiliated with M Health Fairview Southdale Hospital. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Huang to 2 more hospitals, 2 group practices and clinics, 1 dialysis center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Huang practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Huang's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Huang is board certified in hematology by the American Board of Internal Medicine. Dr. Huang has a license on file in Minnesota.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, lung cancer, lymphoma, prostate cancer and purpura and thrombocytopenia among the conditions Dr. Huang treats.

CMS data shows 516 Medicare services from Dr. Huang across 5 procedure codes in 2024, for 230 Medicare patients. Medicare paid $30,062 for them.

CMS counts 230 Medicare patients who saw Dr. Huang in 2024. The largest group is 75 to 84, with 95 patients. 68% of them have cancer, and 64% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Huang's median patient age at 70, with 85% women.

In 2024, Dr. Huang wrote 1,092 Medicare Part D claims for 202 patients. 85% of them were for generic drugs. CMS names the drug for 860 of them, across 21 drugs with 11 or more claims each, at $1,484,240 in total drug cost. In 2023, CMS named 715 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Huang for performance year 2024, reported as part of a group. Dr. Huang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Huang as offering telehealth.

Dmand AI links 11 papers to Dr. Huang, published from 2008 to 2020. 2008 was the busiest year, with 2. The most frequent topics are Primary Myelofibrosis, Erythropoietin and Hemoglobins. Dr. Huang has published most often in Cancer. Dr. Huang's most frequent co-authors are Ayalew Tefferi, MD, Ruben Anthony Mesa, MD and Morton S. Kahlenberg, MD.

CMS Open Payments shows 5 general payments to Dr. Huang from 3 drug and device companies from 2017 to 2025. Education make up the largest share, 100% of the total. Pfizer Inc. paid the most, $78.

Dr. Huang graduated from Pritzker School of Medicine in 2006.

Dr. Huang is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.